04:31 PM EDT, 06/10/2026 (MT Newswires) -- Ideaya Biosciences ( IDYA ) said late Thursday it closed its underwritten public offering, raising about $345 million in gross proceeds before underwriting discounts, commissions and other offering expenses.

The offering included 7.22 million shares of common stock priced at $27 per share and pre-funded warrants to purchase 5.56 million shares of common stock priced at $26.9999 per warrant.

The total also reflects the underwriters' full exercise of an option to purchase an additional 1.67 million shares of common stock.